Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?

ESMO Open

Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester; Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address:

Published: April 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958277PMC
http://dx.doi.org/10.1016/j.esmoop.2023.100879DOI Listing

Publication Analysis

Top Keywords

controversies nsclc
4
nsclc second-line
4
second-line strategy
4
strategy chemo-immunotherapy?
4
controversies
1
second-line
1
strategy
1
chemo-immunotherapy?
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!